跳至主要内容
临床试验/NCT02222129
NCT02222129已完成4 期

A Randomized Controlled Trial for Pain Control in Laparoscopic Urologic Surgery: 0.25% Bupivacaine Versus Long-Acting Liposomal Bupivacaine

Knight, Richard, M.D.2 个研究点 分布在 1 个国家目标入组 206 人开始时间: 2012年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
206
试验地点
2
主要终点
Total Opioid Consumption Measured in Intravenous Morphine Equivalents During the Postoperative Hospital Stay

研究概览

简要总结

A prospective, randomized comparison of bupivacaine to liposomal bupivacaine given by local injection at all the wound sites in patients undergoing robotic-assisted or laparoscopic urologic surgeries in an effort to determine which method reduced postoperative opioid use the most.

详细描述

Liposomal bupivacaine was developed to extend the duration of efficacy of bupivacaine from the typical 6 - 8 hours up to 72 hours. The prolonged duration of liposomal bupivacaine was initially demonstrated in mice in 1994. Two randomized controlled trials using liposomal bupivacaine for bunionectomy and hemorrhoidectomy resulted in FDA approval for its use in humans. More recently, liposomal bupivacaine has also been found to improve pain control for patients undergoing total knee arthroplasty. Infiltration of a local anesthetic into laparoscopic port sites is a common practice that has been shown in some studies to improve postoperative pain. To compare liposomal bupivacaine and 0.25% bupivacaine for local analgesia following laparoscopic and robotic urologic surgery, a randomized comparison-controlled trial was performed.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • At least 18-years-old, undergoing laparoscopic urologic surgery.

排除标准

  • Pregnant and/or nursing mothers.
  • Allergy to bupivacaine.

研究组 & 干预措施

Bupivacaine

Active Comparator

Surgical site infiltration of 0.25% bupivacaine.

干预措施: Bupivacaine (Drug)

Liposomal bupivacaine

Experimental

Surgical site infiltration of liposomal bupivacaine.

干预措施: liposomal bupivacaine (Drug)

结局指标

主要结局

Total Opioid Consumption Measured in Intravenous Morphine Equivalents During the Postoperative Hospital Stay

时间窗: All data was recorded during the patient's hospital stay, typically less than 5 days. All data was tabulated from the electronic medical record, typically within 30 days of discharge from hospital.

Total opioid consumption measured in intravenous morphine equivalents during the postoperative hospital stay

次要结局

  • Visual Analog Pain Scores.(All data was recorded during the patient's hospital stay, typically less than 5 days. All data was tabulated from the electronic medical record, typically within 30 days of discharge from hospital.)
  • Length of Hospital Stay.(All data was recorded during the patient's hospital stay, typically less than 5 days. All data was tabulated from the electronic medical record, typically within 30 days of discharge from hospital.)
  • Time to First Opioid Use.(All data was recorded during the patient's hospital stay, typically less than 5 days. All data was tabulated from the electronic medical record, typically within 30 days of discharge from hospital.)

研究者

发起方
Knight, Richard, M.D.
申办方类型
Indiv
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Efficacy of Liposomal Bupivacaine Versus 0.25%... | 临床试验